Standout Papers

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease 2001 2026 2009 2017 1.7k
  1. Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease (2001)
    Curt R. Freed, Paul Greene et al. New England Journal of Medicine
  2. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial (2007)
    Michael G. Kaplitt, Andrew Feigin et al. The Lancet
  3. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease (2022)
    Brage Brakedal, Christian Dölle et al. Cell Metabolism
  4. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease (2025)
    Viviane Tabar, Harini Sarva et al. Nature

Immediate Impact

7 by Nobel laureates 11 from Science/Nature 77 standout
Sub-graph 1 of 18

Citing Papers

Parkinson’s Disease
2024 Standout
Hallmarks of aging: An expanding universe
2023 Standout
29 intermediate papers

Works of David Eidelberg being referenced

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
2022 Standout
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
and 16 more

Author Peers

Author Last Decade Papers Cites
David Eidelberg 13672 8204 5461 356 21.8k
Klaus L. Leenders 8083 6158 2923 296 17.0k
José Á. Obeso 20522 10552 5175 305 28.1k
Marie Vidailhet 12924 5848 3130 337 17.3k
Thomas Foltynie 14866 7169 4437 281 19.8k
Eduardo Tolosa 19292 6270 4615 384 25.9k
Aldo Quattrone 7325 5033 2170 525 15.4k
Jane S. Paulsen 8362 10769 3642 334 19.9k
Roger L. Albin 10425 11466 3536 308 21.4k
Jun Kimura 6088 5415 2371 399 18.2k
Jens Volkmann 14470 7724 4381 365 20.4k

All Works

Loading papers...

Rankless by CCL
2026